Table 7.
A. de Souza, 2023 [68] | ||||||
---|---|---|---|---|---|---|
Antisynthetase Antibody | Frequency in Myositis | Frequency of ILD | NSIP Pattern | UIP Pattern | OP Pattern |
DAD Pattern |
Jo-1 | 15–30% | 70–80% | 10% | 25% | 5% | 50% |
PL7 | 5–10% | 84% | 25% | 50% | 50% | - |
PL12 | <5% | 90% | 17% | 67% | 17% | - |
KS | 1% | 90% | 62% | 27–35% | - | - |
OJ | 1% | 8% | - | - | - | - |
EJ | 1% | >90% | 75% | 4% | 21% | - |
Ha | <1% | 60–100% | - | 21% | - | - |
Zo | <1% | 4–38% | 60% | 10% | 30% | - |
B. Jiang, 2021 [69] | ||||||
Autoantibody n = 84 (n) | NSIP | OP | NSIP + OP | UIP | Unclassifiable | |
Jo-1 (36) | 44.5% | 27.8% | 19.4% | 0% | 8.3% | |
PL7 (22) | 50.0% | 18.2% | 22.7% | 9.1% | 0% | |
PL12 (9) | 22.2% | 33.3% | 22.2% | 11.1% | 11.1% | |
EJ (12) | 58.3% | 33.3% | 8.3% | 0% | 0% | |
OJ (5) | 20.0% | 0% | 20.0% | 40.0% | 20.0% |